Logo-ipp
Submitted: 14 Jan 2016
Accepted: 03 Mar 2016
ePublished: 20 Mar 2016
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Immunopathol Persa. 2016;2(2): e19-.
  Abstract View: 2505
  PDF Download: 1541

Original Article

Immunostaining of podocyte associate markers in renal biopsies; a valuable adjunct in characterisation of podocytopathies

Sonia Badwal 1*, Arun Kumar 2, Shilpi Singh 3, Vibha Dutta 1

1 Department of Laboratory Sciences and Molecular Medicine, Army Hospital (Research & Referral), Delhi Cantt, India
2 Department of Medicine and Nephrology, Command Hospital (CC), Lucknow, UP, India
3 Department of Pathology, 155 Base Hospital, India
*Corresponding Author: Correspondence to Sonia Badwal, Email: soniabadwal06@gmail.com

Abstract

Introduction: Glomerular diseases comprise a wide spectrum of histopathological appearances within a clinically defined diagnosis of nephrotic syndrome (NS). Many of glomerular diseases are the result of genetic mutations encoding podocytic markers.

Objective: Our aim in this study was to offer a framework that integrates renal morphology with podocytopathies to facilitate management strategies and prognostic information.

Materials and Methods: Descriptive study of 50 cases of NS along with 50 controls wherein a combination of histopathological examination, morphometric studies, immunohistochemistry, direct and indirect immunofluorescence (IFF) were employed for evaluation of podocyte markers (podocin and nephrin) in renal biopsies. The clinical and demographic profile, management received and follow up was recorded for each patient and correlated with renal biopsy.

Results: All control renal tissues (n=50) exhibited linear glomerular basement membrane (GBM) staining. To maintain homogeneity we analyzed patients of minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), mesangial hypercellularity and diffuse mesangial sclerosis (DMS) and we grouped them as ‘podocytopathies’ (n = 38). All cases (n = 38) exhibited evidence of podocyte injury as evident by change of linear GBM positivity to granular pattern or complete absence of podocin (07/38, 14%)) or nephrin (3/38, 7.8%). No histopathological variable predicted clinical response (P = 0.260). The integrated diagnosis formulated by incorporating glomerular morphology and podocyte molecular phenotype strongly correlated with steroid resistance and outcome. (χ2 = 26.437, P < 0.001and χ2 = 25.73, P < 0.001).

Conclusion: Evaluating podocytopathies in a more systematic manner by incorporating podocyte markers in the work up will facilitate more planned approach to diagnosis and management. 


Citation: Badwal S, Kumar A, Singh S, Dutta V. Immunostaining of podocyte associate markers in renal biopsies; a valuable adjunct in characterisation of podocytopathies. Immunopathol Persa. 2016;2(2):e19.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 2506

Your browser does not support the canvas element.


PDF Download: 1541

Your browser does not support the canvas element.